TFRC has been reported to be significantly upregulated in a variety of tumors, including bladder cancer and hepatocarcinoma, where it plays a crucial role in promoting tumor cell proliferation, invasion, metastasis, as well as conferring resistance to radiotherapy and chemotherapy (Tang et al., 2024; Wang et al., 2023a). The gene discussed is TFRC; the disease is neoplasm.